Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs

被引:353
作者
Sun, DX
Lennernas, H
Welage, LS
Barnett, JL
Landowski, CP
Foster, D
Fleisher, D
Lee, KD
Amidon, GL
机构
[1] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[2] Univ Uppsala, Dept Pharm, Grp Biopharmaceut, S-75123 Uppsala, Sweden
[3] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
关键词
gene expression; transporter; GeneChip (R); permeability; in vivo/in vitro correlation;
D O I
10.1023/A:1020483911355
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To compare gene expression profiles and drug permeability differences in Caco-2 cell culture and human duodenum. Methods. Gene expression profiles in Caco-2 cells and human duodenum were determined by GeneChip(R) analysis. In vivo drug permeability measurements were obtained through single-pass intestinal perfusion in human subjects, and correlated with in vitro Caco-2 transport permeability. Results. GeneChip(R) analysis determined that 37, 47, and 44 percent of the 12,559 gene sequences were expressed in 4-day and 16-day Caco-2 cells and human duodenum, respectively. Comparing human duodenum with Caco-2 cells, more than 1000 sequences were determined to have at least a 5-fold difference in expression. There were 26, 38, and 44 percent of the 443 transporters, channels, and metabolizing enzymes detected in 4-day, 16-day Caco-2 cells, and human duodenum, respectively. More than 70 transporters and metabolizing enzymes exhibited at least a 3-fold difference. The overall coefficient of variability of the 10 human duodenal samples for all expressed sequences was 31% (range 3% to 294%) while that of the expressed transporters and metabolizing enzymes was 33% (range 3% to 87%). The in vivo / in vitro drug permeability measurements correlated well for passively absorbed drugs (R-2 = 85%). The permeability correlation for carrier-mediated drugs showed 3- 35-fold higher in human above the correlation of passively absorbed drugs. The 2- 595-fold differences in gene expression levels between the Caco-2 cells and human duodenum correlated with the observed 3- 35-fold difference in permeability correlation between carrier-mediated drugs and passively absorbed drugs. Conclusions. Significant differences in gene expression levels in Caco-2 cells and human duodenum were observed. The observed differences of gene expression levels were consistent with observed differences in carrier mediated drug permeabilities. Gene expression profiling is a valuable new tool for investigating in vitro and in vivo permeability correlation.
引用
收藏
页码:1400 / 1416
页数:17
相关论文
共 37 条
[1]   INTESTINAL-ABSORPTION OF AMINO-ACID DERIVATIVES - IMPORTANCE OF THE FREE ALPHA-AMINO GROUP [J].
AMIDON, GL ;
CHANG, M ;
FLEISHER, D ;
ALLEN, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (10) :1138-1141
[2]   ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[5]   EVIDENCE FOR A POLARIZED EFFLUX SYSTEM IN CACO-2 CELLS CAPABLE OF MODULATING CYCLOSPORINE-A TRANSPORT [J].
AUGUSTIJNS, PF ;
BRADSHAW, TP ;
GAN, LSL ;
HENDREN, RW ;
THAKKER, DR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :360-365
[6]   In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system [J].
Chong, SH ;
Dando, SA ;
Soucek, KM ;
Morrison, RA .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :120-123
[7]  
Chu XY, 2001, J PHARMACOL EXP THER, V299, P575
[8]   In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats:: Comparison with rapamycin [J].
Crowe, A ;
Lemaire, M .
PHARMACEUTICAL RESEARCH, 1998, 15 (11) :1666-1672
[9]   ASSOCIATION OF INTESTINAL PEPTIDE-TRANSPORT WITH A PROTEIN RELATED TO THE CADHERIN SUPERFAMILY [J].
DANTZIG, AH ;
HOSKINS, J ;
TABAS, LB ;
BRIGHT, S ;
SHEPARD, RL ;
JENKINS, IL ;
DUCKWORTH, DC ;
SPORTSMAN, JR ;
MACKENSEN, D ;
ROSTECK, PR ;
SKATRUD, PL .
SCIENCE, 1994, 264 (5157) :430-433
[10]   PASSIVE AND CARRIER-MEDIATED INTESTINAL-ABSORPTION COMPONENTS OF 2 ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR PRODRUGS IN RATS - ENALAPRIL AND FOSINOPRIL [J].
FRIEDMAN, DI ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1989, 6 (12) :1043-1047